Genscript Biotech Corp (OTCPK:GNNSF)

$ 1.41 0 (0%) Market Cap: 3.08 Bil Enterprise Value: 1.57 Bil PE Ratio: 0 PB Ratio: 2.52 GF Score: 69/100

Full Year 2023 Genscript Biotech Corp Earnings Call Transcript
Mar 10, 2024

Earnings
Q2 2023 Genscript Biotech Corp Earnings Call Transcript
Aug 20, 2023

Earnings
Full Year 2022 Genscript Biotech Corp Earnings Presentation Transcript
Mar 30, 2023
Q2 2022 Genscript Biotech Corp Earnings Call Transcript
Aug 31, 2022

$3.49

Earnings
Full Year 2021 Genscript Biotech Corp Earnings Call Transcript
Mar 20, 2022

Earnings
Full Year 2020 Genscript Biotech Corp Earnings Call Transcript
Mar 28, 2021

Earnings
Half Year 2020 Genscript Biotech Corp Earnings Call Transcript
Aug 31, 2020

$2.02

Earnings
Genscript Biotech Corp Business Update Meeting Transcript
Aug 02, 2020

Q2 2023 Genscript Biotech Corp Earnings Call Transcript

Aug 20, 2023 / 11:30PM GMT

Transcript

Operator

Hello, and welcome to the GenScript Biotech Interim 2023 Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

It is now my pleasure to introduce IR Director, Pengfei.

Duan Pengfei

Thank you, Andrew. Hi, everyone. Welcome to GenScript 2023 Interim Results Conference Call. I'm Pengfei Duan, Investor Relations Director at GenScript.

Joining me on the call today are Mr. Robin Meng, Chair of the Board; Ms. Sherry Shao, Rotating CEO; Dr. Patrick Liu, Off-duty Rotating CEO; and Mr. Shiniu Wei, CFO of GenScript. We also have key leaders from subsidiaries and business units joining us.

Before we begin, I would like to remind everyone that on today's call we will be making statements about future expectations, plans and prospects as well as any other statements regarding matters that are not historical facts, which may constitute forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements. Because of various important risk factors

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.